Side-by-side financials for CODX and BSX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CODX | BSX |
|---|---|---|
| Market cap | - | $69.72 B |
| US-listed rank | - | #249 |
| Revenue (latest FY) | $622.49K | $20.07B |
| Net income (latest FY) | -$46.90M | - |
| Net margin | -7533.6% | - |
| SEC filings | 355 | 1,009 |
In their latest fiscal years, Co-Diagnostics, Inc. reported $622.49K in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: Co-Diagnostics, Inc. and BOSTON SCIENTIFIC CORP, or browse the full rankings.